Nipro (NPRRF) YoY EBITDA Growth: -6.45% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NPRRF Nipro Corp NPRRF
74 GF Score
Price $9.96
GF Value $10.26
! 6 Warning Signs
View Full Analysis

What is Nipro YoY EBITDA Growth?

Nipro NPRRF 74 YoY EBITDA Growth is -6.45% as of Jun. 2026. GuruFocus rates NPRRF with a GF Score™ of 74/100 and a GF Value™ of $10.26. The stock has 6 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Nipro's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was -6.45%.

Nipro's EBITDA per Share for the three months ended in Jun. 2026 was $0.89.

Nipro YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Nipro's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nipro YoY EBITDA Growth Chart

Nipro Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 -25.50 13.36 3.64 12.55

Nipro Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.95 29.12 18.59 -18.47 -6.45
NPRRF
74GF Score
Nipro Corp NPRRF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nipro YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Nipro's YoY EBITDA Growth for the fiscal year that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (A: Mar. 2026 )
=(EBITDA per Share (A: Mar. 2026 )-EBITDA per Share (A: Mar. 2025 ))/ | EBITDA per Share (A: Mar. 2025 ) |
=(3.713-3.299)/ | 3.299 |
=12.55 %

Nipro's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(0.885-0.946)/ | 0.946 |
=-6.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -6.45% mean?
Nipro (NPRRF) has a YoY EBITDA Growth of -6.45% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Nipro and its competitors.
Is Nipro's YoY EBITDA Growth too high?
Nipro's current YoY EBITDA Growth is -6.45%. Overall, Nipro has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Nipro's YoY EBITDA Growth compare to ISRG and BDX?
Nipro's YoY EBITDA Growth of -6.45% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Devices & Instruments company?
A good YoY EBITDA Growth depends on the Medical Devices & Instruments industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Nipro and its competitors. Nipro's current YoY EBITDA Growth is -6.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nipro stock overvalued right now?
Nipro (NPRRF) has a current YoY EBITDA Growth of -6.45%. The stock's GF Value™ is $10.26, compared to a current price of $9.96 — trading 2.9% below its estimated fair value. The current YoY EBITDA Growth is -6.45%. Nipro's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Nipro (NPRRF), the current YoY EBITDA Growth is -6.45% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nipro (NPRRF) Overvalued in 2026?

Based on GuruFocus' analysis, Nipro stock appears to be undervalued. The current stock price of $9.96 is trading 2.9% below its estimated GF Value™ of $10.26.

Key valuation signals for NPRRF:

  • YoY EBITDA Growth: -6.45%
  • GF Value™: $10.26 vs. price of $9.96 (2.9% below fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the NPRRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nipro Business Description

Other Exchanges 8086:Japan5FA:Germany
Address 3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
74GF Score

Get the complete analysis for NPRRF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.96
Price
$10.26
GF Value